These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 10463586)

  • 1. Decreases in Ikaros activity correlate with blast crisis in patients with chronic myelogenous leukemia.
    Nakayama H; Ishimaru F; Avitahl N; Sezaki N; Fujii N; Nakase K; Ninomiya Y; Harashima A; Minowada J; Tsuchiyama J; Imajoh K; Tsubota T; Fukuda S; Sezaki T; Kojima K; Hara M; Takimoto H; Yorimitsu S; Takahashi I; Miyata A; Taniguchi S; Tokunaga Y; Gondo H; Niho Y; Harada M
    Cancer Res; 1999 Aug; 59(16):3931-4. PubMed ID: 10463586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dominant negative isoform of the Ikaros gene in patients with adult B-cell acute lymphoblastic leukemia.
    Nakase K; Ishimaru F; Avitahl N; Dansako H; Matsuo K; Fujii K; Sezaki N; Nakayama H; Yano T; Fukuda S; Imajoh K; Takeuchi M; Miyata A; Hara M; Yasukawa M; Takahashi I; Taguchi H; Matsue K; Nakao S; Niho Y; Takenaka K; Shinagawa K; Ikeda K; Niiya K; Harada M
    Cancer Res; 2000 Aug; 60(15):4062-5. PubMed ID: 10945610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
    Sun L; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Mao C; Vassilev A; Reaman GH; Uckun FM
    Clin Cancer Res; 1999 Aug; 5(8):2112-20. PubMed ID: 10473095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M
    Hokkaido Igaku Zasshi; 1993 Mar; 68(2):237-50. PubMed ID: 8509066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
    Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
    Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].
    Liu XL; Zhou SY; Du QF; Zheng WY; Zhang S; Song LL; Xu B; Liu QF; Meng FY
    Ai Zheng; 2004 Apr; 23(4):421-5. PubMed ID: 15087031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Ikaros family splicing variants in human hematopoietic lineages.
    Matulić M; Paradzik M; Puskarić BJ; Stipić J; Antica M
    Coll Antropol; 2010 Mar; 34(1):59-62. PubMed ID: 20432734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-DNA-binding Ikaros isoform gene expressed in adult B-precursor acute lymphoblastic leukemia.
    Nishii K; Katayama N; Miwa H; Shikami M; Usui E; Masuya M; Araki H; Lorenzo F; Ogawa T; Kyo T; Nasu K; Shiku H; Kita K
    Leukemia; 2002 Jul; 16(7):1285-92. PubMed ID: 12094252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia.
    Deininger MW; Vieira S; Mendiola R; Schultheis B; Goldman JM; Melo JV
    Cancer Res; 2000 Apr; 60(7):2049-55. PubMed ID: 10766197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of the LHX4 LIM-homeobox gene caused by t(1;14)(q25;q32) in chronic myelogenous leukemia in biphenotypic blast crisis.
    Yamaguchi M; Yamamoto K; Miura O
    Genes Chromosomes Cancer; 2003 Nov; 38(3):269-73. PubMed ID: 14506703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of L-selectin expression by a dominant negative Ikaros protein.
    Christopherson I; Piechoki M; Liu G; Ratner S; Galy A
    J Leukoc Biol; 2001 Apr; 69(4):675-83. PubMed ID: 11310856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia.
    Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T
    Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoallelic deletions of the P53 gene in Chinese patients with chronic myelogenous leukemia in blastic crisis.
    Chen SJ; Wang Q; Tong JH; Xie WJ; Cao Q; Cai JR; Li XS; Wang ZY; Chen Z; Larsen CJ
    Nouv Rev Fr Hematol (1978); 1991; 33(6):481-4. PubMed ID: 1818302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia.
    Barnes DJ; Palaiologou D; Panousopoulou E; Schultheis B; Yong AS; Wong A; Pattacini L; Goldman JM; Melo JV
    Cancer Res; 2005 Oct; 65(19):8912-9. PubMed ID: 16204063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
    Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
    J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative expression of different Ikaros isoforms in childhood acute leukemia.
    Meleshko AN; Movchan LV; Belevtsev MV; Savitskaja TV
    Blood Cells Mol Dis; 2008; 41(3):278-83. PubMed ID: 18675565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.